Erratum: Spinal deformity index in patients with type 2 diabetes (Endocrine DOI: 10.1007/s12020-012-9848-z);Spinal deformity index in patients with type 2 diabetes

Endocrine

Volumn 43, Issue 3, 2013, Pages 651-658

  Di Somma, C ^a   Rubino, M ^b   Faggiano, A ^b,c   Vuolo, L ^b   Contaldi, P ^b   Tafuto, N ^d   Andretti, M ^d   Savastano, S ^b   Colao, A ^b  

^a IRCCS SDN   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d Centro Medicina Preventiva (CMP) Quarto   (Italy)

Author keywords

Diabetes mellitus Type 2; Fragility fractures; SDI

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; HEMOGLOBIN A1C; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALYTICAL PARAMETERS; AREA UNDER THE CURVE; ARTICLE; BODY MASS; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE QUALITY; CALCIUM URINE LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERPARATHYROIDISM; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; MUSCULOSKELETAL SYSTEM PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOPENIA; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SENSIBILITY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SPINAL DEFORMITY INDEX; SPINE FRACTURE; SPINE RADIOGRAPHY; THORACIC SPINE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 84877875462     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9882-5     Document Type: Erratum

References (48)

1. K.K. Nicodemus, A.R. Folsom, Iowa Women's Health Study: type 1 and 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 24, 1192-1197 (2001)
2. G.C. Isaia, P. Ardissone, M. Di Stefano, D. Ferrari, V. Martina, M. Porta, M. Tagliabue, G.M. Molinatti, Bone metabolism in type 2 diabetes mellitus. Acta Diabetol. 36, 35-38 (1999)
3. R.Q. Ivers, R.G. Cumming, P. Mitchell, A.J. Peduto, Blue Mountains Eye Study.: diabetes and risk of fracture: the Blue Mountains Eye Study. Diabetes Care 24, 1198-1203 (2001)
4. P. McNair, S. Madsbad, M.S. Christensen, C. Christiansen, O.K. Faber, C. Binder, I. Transbøl, Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol. 90, 463-472 (1979)
5. G. Hein, R. Wiegand, G. Lehmann, G. Stein, S. Franke, Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis. Rheumatology (Oxford) 42, 1242-1246 (2003)
6. G. Hein, R. Wiegand, G. Lehmann, G. Stein, S. Franke, Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann. Rheum. Dis. 65, 101-104 (2006)
7. P. Odetti, S. Rossi, F. Monacelli, A. Poggi, M. Cirnigliaro, M. Federici, A. Federici, Advanced glycation end products and bone loss during aging. Ann. N. Y. Acad. Sci. 1043, 710-717 (2005)
8. M. Saito, K. Fujii, S. Soshi, T. Tanaka, Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos. Int. 17(7), 986-995 (2006)
9. S. Yamagishi, K. Nakamura, H. Inoue, Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients. Med. Hypotheses 65, 1013-1015 (2005)
10. M. Rix, H. Andreassen, P. Eskildsen, Impact of peripheral neuropathy on bone density in patients with type 1 diabetes. Diabetes Care 22, 827-831 (1999)
11. D. Hadjidakis, Bone mineral density in type II diabetics with macroangiopathy. J. Bone Miner. Res. 12(Suppl 1), S516 (1997)
12. M.S. Maurer, J. Burcham, H. Cheng, Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility. J. Gerontol. A. Biol. Sci. Med. Sci. 60, 1157-1162 (2005)
13. J.P. Williams, H.C. Blair, J.M. McDonald, M.A. McKenna, S.E. Jordan, J. Williford, R.W. Hardy, Regulation of osteoclastic bone resorption by glucose. Biochem. Biophys. Res. Commun. 235, 646e51 (1997)
14. D. Vashishth, G.J. Gibson, J.I. Khoury, M.B. Schaffler, J. Kimura, D.P. Fyhrie, Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28, 195-201 (2001)
15. M. Saito, K. Marumo, Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos. Int. 21, 195-214 (2010)
16. S. Viguet-Carrin, J.P. Roux, M.E. Arlot, Z. Merabet, D.J. Leeming, I. Byrjalsen, P.D. Delmas, M.L. Bouxsein, Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone 39, 1073-1079 (2006)
17. P. Vestergaard, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos. Int. 18, 427-444 (2007)
18. J.F. Griffith, H.K. Genant, New advances in imaging osteoporosis and its complications. Endocrine 42(1), 39-51 (2012)
19. G.G. Crans, H.K. Genant, J.H. Krege, Prognostic utility of a semiquantitative spinal deformity index. Bone 37, 175-179 (2005)
20. H.K. Genant, P.D. Delmas, P. Chen, Y. Jiang, E.F. Eriksen, G.P. Dalsky, R. Marcus, J. San Martin, Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos. Int. 18, 69-76 (2007)
21. Expert Committee on the Diagnosis and Classification of diabetes mellitus, Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(suppl 1), S5-S20 (2003)
22. C. Tsigos, V. Hainer, A. Basdevant, N. Finer, M. Fried, E. Mathus-Vliegen, D. Micic, M. Maislos, G. Roman, Y. Schutz, H. Toplak, B. Zahorska-Markiewicz, Obesity management task force of the European Association for the study of obesity. Management of obesity in adults: European clinical practice guidelines. Obes. Facts 1(2), 106-116 (2008)
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive summary of third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486-2497 (2001)
24. M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, R.P. Heaney, M.H. Murad, C.M. Weaver, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(7), 1911-1930 (2011)
25. World Health Organization, Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ. Tech. Rep. Ser. 843, 1-129 (1994)
26. Y. Fukunaga, Does insulin use increase bone mineral density in patients with non-insulin-dependent diabetes mellitus? Arch. Intern. Med. 157, 2668-2669 (1997)
27. E. Barret-Connor, D. Kritz-Silverstein, Does Hyperinsulinemia preserve bone? Diabetes Care 19, 1388-1392 (1996)
28. L. Forsen, H.E. Meyer, K. Midthjell, T.H. Edna, Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 42, 920-925 (1999)
29. E. Canalis, G. Mazziotti, A. Giustina, J.P. Bilezikian, Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos. Int. 18(10), 1319-1328 (2007)
30. G. Mazziotti, A. Bianchi, S. Bonadonna, M. Nuzzo, V. Cimino, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. 21(4), 520-528 (2006)
31. G. Mazziotti, A. Bianchi, S. Bonadonna, V. Cimino, I. Patelli, A. Fusco, A. Pontecorvi, L. De Marinis, A. Giustina, Prevalence of Vertebral Fractures in Men with Acromegaly. J. Clin. Endocrinol. Metab. 93, 4649-4655 (2008)
32. C. Torti, G. Mazziotti, P.A. Soldini, E. Focà, R. Maroldi, D. Gotti, G. Carosi, A. Giustina, High prevalence of radiological vertebral fractures in HIV-infected males. Endocrine 41(3), 512-517 (2012)
33. C. Gazzaruso, An increased risk for fractures: another cause of frailty in HIV-infected subjects. Endocrine 41(3), 347-349 (2012)
34. A.V. Schwartz, D.E. Sellmeyer, K.E. Ensrud, J.A. Cauley, H.K. Tabor, P.J. Schreiner, S.A. Jamal, D.M. Black, S.R. Cummings, Study of Osteoporotic Features Research Group. Older women with diabetes have an increased risk of fracture: a prospective study. J. Clin. Endocrinol. Metab. 86, 32-38 (2001)
35. T. Mancini, G. Mazziotti, M. Doga, R. Carpinteri, N. Simetovic, P.P. Vescovi, A. Giustina, Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Bone 45(4), 784-788 (2009)
36. D.E. Bonds, J.C. Larson, A.V. Schwartz, E.S. Strotmeyer, J. Robbins, B.L. Rodriguez, K.C. Johnson, K.L. Margolis, Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J. Clin. Endocrinol. Metab. 91, 3404-3410 (2006)
37. I.I. de Liefde, M. van der Klift, C.E. de Laet, P.L. van Daele, A. Hofman, H.A. Pols, Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos. Int. 16, 1713-1720 (2005)
38. D.M. Black, N.K. Arden, L. Palermo, J. Pearson, S.R. Cummings, Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 14, 821-828 (1999)
39. NIH Consensus Development Panel Osteoporosis prevention diagnosis and therapy, Osteoporosis prevention, diagnosis, and therapy. JAMA 285, 785-795 (2001)
40. I. Chiodini, V. Morelli, B. Masserini, A.S. Salcuni, C. Eller-Vainicher, R. Viti, F. Coletti, G. Guglielmi, C. Battista, V. Carnevale, L. Iorio, P. Beck-Peccoz, M. Arosio, B. Ambrosi, A. Scillitani, Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism:an Italian multicenter study. J. Clin. Endocrinol. Metab. 94(9), 3207-3214 (2009)
41. M. Lunt, P. Masaryk, C. Scheidt-Nave, J. Nijs, G. Poor, H. Pols, J.A. Falch, G. Hammermeister, D.M. Reid, L. Benevolenskaya, K. Weber, J. Cannata, T.W. O'Neill, D. Felsenberg, A.J. Silman, J. Reeve, The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS Study. Osteoporos. Int. 12, 688-698 (2001)
42. K.C. Chiu, A. Chu, V.L. Go, M.F. Saad, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 79, 820-825 (2004)
43. S. Kumar, M. Davies, Y. Zakaria, E.B. Mawer, C. Gordon, A.O. Olukoga, A.J. Boulton, Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad. Med. J. 70, 440-443 (1994)
44. A. Zittermann, Vitamin D in preventive medicine: are we ignoring the evidence? Br. J. Nutr. 89, 552-572 (2003)
45. D.D. Bikle, Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. Endocr. Rev. 13, 765-784 (1992)
46. J.J. Cao, Effects of obesity on bone metabolism. J. Orthop. Surg. Res. 15, 6-30 (2011)
47. G. Musso, Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block. Endocrine 42(2), 237-239 (2012)
48. G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41(1), 58-69 (2012)